Loxapine
ATC N05AH01 · 8 markets · 89 records
US 25 records · 5 strengths
- 25 mgcapsuleNo trade name
- 50 mgcapsuleNo trade name
- 10 mgcapsuleNo trade name
- 10 mginhalationAdasuve
- 5 mgcapsuleNo trade name
CA 12 records · 6 strengths
- 25 mgtabletAPO-LOXAPINELoxapine、PMS-LOXAPINE
- 10 mgtabletAPO-LOXAPINELoxapine、PMS-LOXAPINE
- 50 mgtabletAPO-LOXAPINELoxapine
- 5 mgtabletAPO-LOXAPINELoxapine
- 2.5 mgtabletPMS-LOXAPINE
- 50 mgliquidLOXAPAC IM
GB 5 records · 5 strengths
- 25 mgcapsuleLoxapac 10mg capsules
- 50 mgcapsuleLoxapac 10mg capsules
- 10 mgcapsuleLoxapac 10mg capsules
- 9.1 mginhalationAdasuve 9.1mg/dose inhalation powder
- 100 mgtabletLoxapac 10mg capsules
TW 3 records · 1 strengths
- 25 mgcapsule"派頓"樂神健膠囊25公絲''約克'' 樂寶膠囊25 毫克、LOPAC CAPSULES 25MG "Y.K."、LOSAGEN CAPSULE 25MG "PATRON"、ROSUP CAPSULES 25MG "SWISS" (LOXAPINE)、瑞平膠囊25毫克(慮平)
CN 1 records · 1 strengths
- 10 mginhalationManufacturer: FerrerInternacional,S.A.
ES 1 records · 1 strengths
- 9.1 mginhalationAdasuve
HK 1 records · 1 strengths
Records without a stated strength · 1 ADASUVE INHALATION POWDER, PRE-DISPENSED 9.1MG
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Adasuve
| Strength / form / release | US | GB | CA | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|
| 25 mg capsule | No trade name | Loxapac 10mg capsules | "派頓"樂神健膠囊25公絲 ''約克'' 樂寶膠囊25 毫克 LOPAC CAPSULES 25MG "Y.K." | |||||
| 25 mg tablet | APO-LOXAPINE Loxapine PMS-LOXAPINE | |||||||
| 10 mg tablet | APO-LOXAPINE Loxapine PMS-LOXAPINE | |||||||
| 50 mg tablet | APO-LOXAPINE Loxapine | |||||||
| 5 mg tablet | APO-LOXAPINE Loxapine | |||||||
| 50 mg capsule | No trade name | Loxapac 10mg capsules | ||||||
| 10 mg capsule | No trade name | Loxapac 10mg capsules | ||||||
| 10 mg inhalation | Adasuve | Manufacturer: FerrerInternacional,S.A. | ||||||
| 9.1 mg inhalation | Adasuve 9.1mg/dose inhalation powder | Adasuve | ||||||
| 100 mg tablet | Loxapac 10mg capsules | |||||||
| 2.5 mg tablet | PMS-LOXAPINE | |||||||
| 5 mg capsule | No trade name | |||||||
| 50 mg liquid | LOXAPAC IM | |||||||
unknown | ADASUVE INHALATION POWDER, PRE-DISPENSED 9.1MG | Adasuve |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in GB · ES · HK · EU and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en GB · ES · HK · EU que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 GB · ES · HK · EU 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 GB · ES · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.